Although the numbers were small, these data showed that cancers were diagnosed later in anti-CCAR1–positive patients than their anti-CCAR1–negative counterparts (median time from DM onset 4.3 vs. 0.85 years, respectively; P = 0.006). The gene discussed is CCAR1; the disease is dermatomyositis.